Nisa Investment Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8K | Sell |
1,260
-958
| -43% | -$8.99K | ﹤0.01% | 2190 |
|
|
2025
Q1 | $15.8K | Buy |
2,218
+1,382
| +165% | +$9.83K | ﹤0.01% | 1976 |
|
|
2024
Q4 | $9.75K | Sell |
836
-288
| -26% | -$3.36K | ﹤0.01% | 2143 |
|
|
2024
Q3 | $23.1K | Buy |
1,124
+56
| +5% | +$1.15K | ﹤0.01% | 1870 |
|
|
2024
Q2 | $23.9K | Sell |
1,068
-1,228
| -53% | -$27.5K | ﹤0.01% | 1884 |
|
|
2024
Q1 | $63.2K | Sell |
2,296
-64
| -3% | -$1.76K | ﹤0.01% | 1601 |
|
|
2023
Q4 | $72K | Sell |
2,360
-100
| -4% | -$3.05K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $77.8K | Sell |
2,460
-59,990
| -96% | -$1.9M | ﹤0.01% | 1588 |
|
|
2023
Q2 | $2.55M | Buy |
62,450
+60,470
| +3,054% | +$2.47M | 0.02% | 609 |
|
|
2023
Q1 | $74K | Buy |
1,980
+20
| +1% | +$747 | ﹤0.01% | 1598 |
|
|
2022
Q4 | $68K | Sell |
1,960
-112
| -5% | -$3.89K | ﹤0.01% | 1681 |
|
|
2022
Q3 | $109K | Buy |
2,072
+552
| +36% | +$29K | ﹤0.01% | 1465 |
|
|
2022
Q2 | $79K | Sell |
1,520
-350
| -19% | -$18.2K | ﹤0.01% | 1572 |
|
|
2022
Q1 | $136K | Sell |
1,870
-1,220
| -39% | -$88.7K | ﹤0.01% | 1517 |
|
|
2021
Q4 | $292K | Sell |
3,090
-23,401
| -88% | -$2.21M | ﹤0.01% | 1156 |
|
|
2021
Q3 | $3.55K | Buy |
26,491
+23,441
| +769% | +$3.15K | 0.02% | 549 |
|
|
2021
Q2 | $494 | Hold |
3,050
| – | – | ﹤0.01% | 1142 |
|
|
2021
Q1 | $245 | Hold |
3,050
| – | – | ﹤0.01% | 1416 |
|
|
2020
Q4 | $166K | Buy |
3,050
+950
| +45% | +$51.7K | ﹤0.01% | 1551 |
|
|
2020
Q3 | $42K | Buy |
+2,100
| New | +$42K | ﹤0.01% | 1860 |
|
|
2018
Q4 | – | Sell |
-17,100
| Closed | -$489K | – | 1976 |
|
|
2018
Q3 | $489K | Buy |
17,100
+9,100
| +114% | +$260K | ﹤0.01% | 1101 |
|
|
2018
Q2 | $219K | Hold |
8,000
| – | – | ﹤0.01% | 1243 |
|
|
2018
Q1 | $169K | Hold |
8,000
| – | – | ﹤0.01% | 1272 |
|
|
2017
Q4 | $154K | Hold |
8,000
| – | – | ﹤0.01% | 1313 |
|
|
2017
Q3 | $199K | Buy |
8,000
+100
| +1% | +$2.49K | ﹤0.01% | 1251 |
|
|
2017
Q2 | $134K | Buy |
+7,900
| New | +$134K | ﹤0.01% | 1309 |
|